Clinical Trial Update: Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating CUSA-081 for restoring central venous access device function in catheter occlusion and thrombosis was terminated, with results and sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheter Occlusion
• Thrombosis

Drugs mentioned

• CUSA-081

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Catheter Occlusion, Thrombosis | Phase 3 | Status: TERMINATED | Results posted: 2024-08-23